相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation
Iskra Pusic et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
AMD3100 plus G-CSF can successfully mobilize CD34+cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: compassionate use data
G. Calandra et al.
BONE MARROW TRANSPLANTATION (2008)
Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation
Shirong Wang et al.
TRANSFUSION (2007)
Patients mobilizing large numbers of CD34+ cells ('super mobilizers') have improved survival in autologous stem cell transplantation for lymphoid malignancies
B. J. Bolwell et al.
BONE MARROW TRANSPLANTATION (2007)
Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myeloma
S. Kumar et al.
LEUKEMIA (2007)
Relapse risk after autologous transplantation in patients with newly diagnosed myeloma is not related with infused tumor cell load and the outcome is not improved by CD34+cell selection: long term follow-up of an EBMT phase III randomized study
Jean-Henri Bourhis et al.
HAEMATOLOGICA (2007)
Phase I trial of parathyroid hormone to facilitate stem cell mobilization
Karen K. Ballen et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
Serum M-spike and transplant outcome in patients with multiple myeloma
David Dingli et al.
CANCER SCIENCE (2007)
Myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma at the time of second or subsequent remission: Long-term follow-up
Ama Z. S. Rohatiner et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Efficient mobilization of peripheral blood stem cells following CAD chemotherapyand a single dose of pegylated G-CSF in patients with multiple myeloma
S. Fruehauf et al.
BONE MARROW TRANSPLANTATION (2007)
Optimizing the timing of chemotherapy for mobilizing autologous blood hematopoietic progenitor cells
Michelle L. Hicks et al.
TRANSFUSION (2007)
Therapeutic targeting of a stem cell niche
Gregor B. Adams et al.
NATURE BIOTECHNOLOGY (2007)
Cytokines and hematopoietic stem cell mobilization
Bruno Nervi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Sustained G-CSF plasma levels following administration of pegfilgrastim fasten neutrophil reconstitution after high-dose chemotherapy and autologous blood stem cell transplantation in patients with multiple myeloma
Roland Fenk et al.
EXPERIMENTAL HEMATOLOGY (2006)
Mechanisms of hematopoietic stem cell mobilization:: When innate immunity assails the cells that make blood and bone
Ingrid G. Winkler et al.
EXPERIMENTAL HEMATOLOGY (2006)
Low doses of GM-CSF (molgramostim) and G-CSF (filgrastim) after cyclophosphamide (4g/m2) enhance the peripheral blood progenitor cell harvest:: results of two randomized studies including 120 patients
P. Quittet et al.
BONE MARROW TRANSPLANTATION (2006)
Peripheral blood stem cell mobilization:: The CXCR2 ligand GROβ rapidly mobilizes hematopoietic stem cells with enhanced engraftment properties
Louis M. Pelus et al.
EXPERIMENTAL HEMATOLOGY (2006)
Risk factors before autologous stem-cell transplantation for lymphoma predict for secondary myelodysplasia and acute myelogenous leukemia
Matt Kalaycio et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Functional regulatory T cells are collected in stem cell autografts by mobilization with high-dose cyclophosphamide and granulocyte colony-stimulating factor
Maud Condomines et al.
JOURNAL OF IMMUNOLOGY (2006)
Timing of autologous stem cell transplantation from last chemotherapy affects lymphocyte collection and survival in non-Hodgkin lymphoma
Shernan G. Holtan et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Mechanisms of disease: Lineage-specific hematopoietic growth factors
K Kaushansky
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Poor mobilization is an independent prognostic factor in patients with malignant lymphomas treated by peripheral blood stem cell transplantation
V Pavone et al.
BONE MARROW TRANSPLANTATION (2006)
Predictive factors for survival in myeloma patients who undergo autologous stem cell transplantation: a single-centre experience in 211 patients
D O'Shea et al.
BONE MARROW TRANSPLANTATION (2006)
Cyclophosphamide mobilization does not improve outcome in patients receiving stem cell transplantation for multiple myeloma
David Dingli et al.
CLINICAL LYMPHOMA & MYELOMA (2006)
CD34+cell adhesion molecule profiles differ between patients mobilized with granulocyte-colony-stimulating factor alone and chemotherapy followed by granulocyte-colony-stimulating factor
CD Ford et al.
TRANSFUSION (2006)
G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow
CL Semerad et al.
BLOOD (2005)
Impact of different strategies of second-line stem cell harvest on the outcome of autologous transplantation in poor peripheral blood stem cell mobilizers
R Goterris et al.
BONE MARROW TRANSPLANTATION (2005)
The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone
N Flomenberg et al.
BLOOD (2005)
Hematopoietic stem cell mobilization with intravenous melphalan and G-CSF in patients with chemoresponsive multiple myeloma: report of a phase II trial
S Gupta et al.
BONE MARROW TRANSPLANTATION (2005)
Successful transplantation of peripheral blood stem cells mobilized by chemotherapy and a single dose of pegylated G-CSF in patients with multiple myeloma
U Steidl et al.
BONE MARROW TRANSPLANTATION (2005)
Successful mobilization of peripheral blood stem cells using recombinant human stem cell factor in heavily pretreated patients who have failed a previous attempt with a granulocyte colony-stimulating factor-based regimen
MA Dawson et al.
BONE MARROW TRANSPLANTATION (2005)
Soluble c-kit receptor mobilizes hematopoietic stem cells to peripheral blood in mice
Y Nakamura et al.
EXPERIMENTAL HEMATOLOGY (2004)
Favourable results with a single autologous stem cell transplant following conditioning with busulphan and cyclophosphamide in patients with multiple myeloma
AA Toor et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
What is the optimum number of CD34+ peripheral blood stem cells for an autologous transplant?
AP Jillella et al.
STEM CELLS AND DEVELOPMENT (2004)
Factors for PBPC collection efficiency and collection predictors
K Ikeda et al.
TRANSFUSION AND APHERESIS SCIENCE (2004)
Characterization of hematopoietic progenitor mobilization in protease-deficient mice
JP Levesque et al.
BLOOD (2004)
Neutrophil-derived MMP-9 mediates synergistic mobilization of hematopoietic stem and progenitor cells by the combination of G-CSF and the chemokines GRO beta/CXCL2 and GRO beta(T)/CXCL2 Delta(4)
LM Pelus et al.
BLOOD (2004)
Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma
M Arora et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2004)
Relation between harvest success and outcome after autologous peripheral blood stem cell transplantation in multiple myeloma
A Wahlin et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2004)
Cytokines alone for PBPC collection in patients with advanced gynaecological malignancies: G-CSF vs G-CSF plus EPO
A Perillo et al.
BONE MARROW TRANSPLANTATION (2004)
Analysis of remobilization success in patients undergoing autologous stem cell transplants who fail an initial mobilization: risk factors, cytokine use and cost
S Boeve et al.
BONE MARROW TRANSPLANTATION (2004)
Single versus double autologous stem-cell transplantation for multiple myeloma
M Attal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Recombinant human thrombopoietin augments mobilization of peripheral blood progenitor cells for autologous transplantation
C Linker et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2003)
High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma
JA Child et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Successful mobilization of peripheral blood stem cells after addition of ancestim (stem cell factor) in patients who had failed a prior mobilization with filgrastim (granulocyte colony-stimulating factor) alone or with chemotherapy plus filgrastim
LB To et al.
BONE MARROW TRANSPLANTATION (2003)
Low-dose or intermediate-dose cyclophosphamide plus granulocyte colony-stimulating factor for progenitor cell mobilisation in patients with multiple myeloma
E Jantunen et al.
BONE MARROW TRANSPLANTATION (2003)
Poor mobilization of peripheral blood stem cells is a risk factor for worse outcome in lymphoma patients undergoing autologous stem cell transplantation
LN Gordan et al.
LEUKEMIA & LYMPHOMA (2003)
Mobilization of peripheral blood progenitor cells with vinorelbine and granulocyte colony-stimulating factor in multiple myeloma patients is reliable and cost effective
MJ Bargetzi et al.
BONE MARROW TRANSPLANTATION (2003)
Reversibility of CD34 expression on human hematopoietic stem cells that retain the capacity for secondary reconstitution
MA Dao et al.
BLOOD (2003)
High-dose ara-C with autologous peripheral blood progenitor cell support induces a marked progenitor cell mobilization:: an indication for patients at risk for low mobilization
C Tarella et al.
BONE MARROW TRANSPLANTATION (2002)
Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4
S Hatse et al.
FEBS LETTERS (2002)
Engraftment syndrome in children undergoing autologous peripheral blood progenitor cell transplantation
L Madero et al.
BONE MARROW TRANSPLANTATION (2002)
Current understanding of stem cell mobilization: The roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells
T Lapidot et al.
EXPERIMENTAL HEMATOLOGY (2002)
Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of Kit-ligand
B Heissig et al.
CELL (2002)
Mobilization by either cyclophosphamide or granulocyte colony-stimulating factor transforms the bone marrow into a highly proteolytic environment
JP Lévesque et al.
EXPERIMENTAL HEMATOLOGY (2002)
Comparison between granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the mobilization of peripheral blood stem cells
Y Gazitt
CURRENT OPINION IN HEMATOLOGY (2002)
Neutrophils are indispensable for hematopoietic stem cell mobilization induced by interleukin-8 in mice
JFM Pruijt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Development of pancytopenia with neutralizing antibodies to thrombopoietin after multicycle chemotherapy supported by megakaryocyte growth and development factor
RL Basser et al.
BLOOD (2002)
Mobilization of peripheral blood stem cells with high-dose cyclophosphamide or the DHAP regimen plus G-CSF in non-Hodgkin's lymphoma
V Pavone et al.
BONE MARROW TRANSPLANTATION (2002)
The impact of thrombopoietin on clinical practice
R Basser
CURRENT PHARMACEUTICAL DESIGN (2002)
Thrombocytopenia caused by the development of antibodies to thrombopoietin
JZ Li et al.
BLOOD (2001)
AMD3100, a potent and specific antagonist of the stromal cell-derived factor-1 chemokine receptor CXCR4, inhibits autoimmune joint inflammation in IFN-γ receptor-deficient mice
P Matthys et al.
JOURNAL OF IMMUNOLOGY (2001)
Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation
U Narayanasami et al.
BLOOD (2001)
Vascular cell adhesion molecule-1 (CD 106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor
JP Lévesque et al.
BLOOD (2001)
Mini-review - Erythropoietin in stem cell transplantation
CB Miller et al.
BONE MARROW TRANSPLANTATION (2001)
ATP-dependent activation of the intermediate conductance, Ca2+ activated K+ channel, hIK1, is conferred by a C-terminal domain
AC Gerlach et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
A comparison of toxicity following two different doses of cyclophosphamide for mobilization of peripheral blood progenitor cells in 116 multiple myeloma patients
O Fitoussi et al.
BONE MARROW TRANSPLANTATION (2001)
Rapid mobilization of murine hematopoietic stem cells with enhanced engraftment properties and evaluation of hematopoietic progenitor cell mobilization in rhesus monkeys by a single injection of SB-251353, a specific truncated form of the human CXC chemokine GROβ
AG King et al.
BLOOD (2001)
Synergistic mobilization of hemopoietic progenitor cells using concurrent β1 and β2 integrin blockade or β2-deficient mice
T Papayannopoulou et al.
BLOOD (2001)
Differential mobilization of CD34+ cells and lymphoma cells in non-Hodgkin's lymphoma patients mobilized with different growth factors
Y Gazitt et al.
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH (2001)
The phenotypic profile of CD34-positive peripheral blood stem cells in different mobilization regimens
F de Boer et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
Characterization and outcome of hard to mobilize lymphoma patients undergoing autologous stem cell transplantation
MW Sugrue et al.
LEUKEMIA & LYMPHOMA (2000)
Peripheral blood stem cell mobilization with cyclophosphamide in combination with G-CSF, GM-CSF, or sequential GM-CSF/G-CSF in non-Hodgkin's lymphoma patients: A randomized prospective study
Y Gazitt et al.
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH (2000)
Is there any difference in PBPC mobilization between cyclophosphamide plus G-CSF and G-CSF alone in patients with non-Hodgkin's lymphoma?
C Dazzi et al.
LEUKEMIA & LYMPHOMA (2000)
Selection and use of chemotherapy with hematopoietic growth factors for mobilization of peripheral blood progenitor cells
E Olavarria et al.
CURRENT OPINION IN HEMATOLOGY (2000)
Simultaneous administration of G-CSF and GM-CSF for re-mobilization in patients with inadequate initial progenitol cell collections for autologous transplantation
A Bashey et al.
CYTOTHERAPY (2000)
A randomized phase 2 study of PBPC mobilization by stem cell factor and filgrastim in heavily pretreated patients with Hodgkin's disease or non-Hodgkin's lymphoma
P Stiff et al.
BONE MARROW TRANSPLANTATION (2000)
ESHAP and G-CSF is a superior blood stem cell mobilizing regimen compared to cyclophosphamide 1.5 g m(-2) and G-CSF for pre-treated lymphoma patients: a matched pairs analysis of 78 patients
MJ Watts et al.
BRITISH JOURNAL OF CANCER (2000)
分享论文
